The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial

(2019) Wen-Fei Li et al.   INTERNATIONAL JOURNAL OF CANCER

A Pairwise Meta‐Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma

(2019) Pu‐Yun OuYang et al.   ONCOLOGIST

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

(2019) Yuan Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial

(2019) Qi Yang et al.   EUROPEAN JOURNAL OF CANCER

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response

(2019) Sai-Lan Liu et al.   RADIOTHERAPY AND ONCOLOGY

Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study

(2018) R L Hong et al.   ANNALS OF ONCOLOGY

TPF induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: Long term results of a Tunisian series

(2018) N. Toumi et al.   Cancer Radiotherapie

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

(2018) Yu-Pei Chen et al.   CLINICAL CANCER RESEARCH

Role of sequential chemoradiotherapy in stage II and low-risk stage III–IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis

(2018) Cheng Xu et al.   ORAL ONCOLOGY

Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy

(2018) Frank E. Mott et al.   ORAL ONCOLOGY

Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis

(2018) Teng Hwee Tan et al.   RADIOTHERAPY AND ONCOLOGY

Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial

(2018) Hongru Yang et al.   RADIOTHERAPY AND ONCOLOGY

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients

(2018) Wang Fangzheng et al.   Journal of Cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era

(2018) Pei-Jing Li et al.   ORAL ONCOLOGY

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

(2018) Zhen Zeng et al.   Scientific Reports

Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study

(2018) Tongxin Liu et al.   Journal of Cancer

Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis

(2018) Yang Li et al.   Cancer Research and Treatment

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

(2017) Su-Mei Cao et al.   EUROPEAN JOURNAL OF CANCER

Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial

(2017) Lei Chen et al.   EUROPEAN JOURNAL OF CANCER

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

(2016) Li Zhang et al.   LANCET

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

(2016) Ying Sun et al.   LANCET ONCOLOGY

International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents

(2015) Michela Casanova et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up

(2015) Meng-Xia Zhang et al.   EUROPEAN JOURNAL OF CANCER

Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma

(2015) Terence Tan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

(2015) Pierre Blanchard et al.   LANCET ONCOLOGY

Survival benefit of induction chemotherapy in treatment for locally advanced nasopharyngeal carcinoma – A time-to-event meta-analysis

(2015) Yaqi Song et al.   ORAL ONCOLOGY

Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials

(2015) Yu-Pei Chen et al.   Journal of Cancer

The long-term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II study

(2015) Nobukazu Fuwa et al.   Cancer Medicine

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) A. T. C. Chan et al.   ANNALS OF ONCOLOGY

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation

(2011) G. Fountzilas et al.   ANNALS OF ONCOLOGY

How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?

(2010) Shu-Zhen Lai et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Re-Evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging

(2009) Yan-Ping Mao et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma

(2008) Edwin P. Hui et al.   JOURNAL OF CLINICAL ONCOLOGY